A Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia
Central Centrifugal Cicatricial Alopecia
About this trial
This is an interventional treatment trial for Central Centrifugal Cicatricial Alopecia focused on measuring hair loss, scalp symptoms
Eligibility Criteria
Inclusion Criteria: Women who are between the age of eighteen years and sixty-five years Biopsy-proven diagnosis of CCCA Stage II-IV. Must be on stable treatment without changes (on doxycycline, topical steroids, minoxidil and/or post 8 rounds of intralesional steroids) for at least 3 months Exclusion Criteria: Subjects with other forms of hair loss that is not CCCA Prior treatment with light source for alopecia Males are excluded from this study since the prevalence of CCCA in males is so significantly low that it is difficult to find cases in a clinical setting
Sites / Locations
- Wake Forest University Health Sciences, DermatologyRecruiting
Arms of the Study
Arm 1
Experimental
Intervention
Using the Revian Red All LED cap 10 minutes each day for 6 months